glp 1 drugs kidney disease GLP-1 and the kidney: from physiology to pharmacology and outcomes in diabetes GLP-1 receptor agonists are increasingly

Im not craving nicotine anymore. And so this really set off, like, a wave of research in the addiction space of, you know, scientists thinking like, Okay, you know, we know that food reward pathways are overlapped, and we know that, oftentimes, thats what we see in addiction, too

Additionally, GLP-1 RAs have shown potential in mitigating inflammation in diabetic kidney disease by inhibiting angiotensin II signaling, downregulating the receptor for advanced glycation end products, attenuating myelopoiesis, and promoting M2 macrophage polarization in mouse models [65, 66]

Data from WTW's 2024 healthcare survey sheds light on how employers are responding

The AWARE-2 study

And actually, we are trying to bring people to their factory settings

And the storyinteresting here, people think about the long-acting as convenience, but actually the long-acting gave us a flatter, steadier drug profile so that the side effects were less bothersome